This article outlines 5 ASX Predictions for 2026 that Stocks Down Under puts its neck on the line to assert will happen. It has become an annual tradition of ours, and some of these calls we get right, others we don't. Arguably our boldest call in suggesting ANZ would be the best performing big 4…
International Stocks
Last Friday, Channel Infrastructure NZ listed on the ASX as a dual-listing. It is unlike the bulk of Kiwi companies that have listed on the ASX before it in being capped at over NZ$1bn and specialising in fuel transportation and supply. And while the New Zealand economy is in a bad shape, this has not…
Brambles (ASX: BXB) has significantly outperformed the ASX 200 in the past year, gaining nearly 20% even with the drop during the furore over Trump's tariffs.
As a company worth over $30bn that operates across approximately 60 countries worldwide, with its business heavily tied to global trade flows, it is sensitive to tariffs and geopolitical changes…
Many investors will be asking themselves this question: 'What does the Fed rate cut mean for Australia?' This question is always asked, but the answer is a lot less concrete than it would ordinarily be, not least because Australia's RBA will not follow suit, and may even go in a different direction.
What are the Best…
Sherwin Williams (NYSE:SHW) is a near 160-year-old paint company from Cleveland, Ohio capped at over US$85bn.
This company is one we've been watching for a while but think now is a good time to consider it. Theoretically, a paint company should only be growing at GDP. But it has managed to deliver a heck of a lot…
In Australia, we know Colgate (NYSE:CL) primarily as a toothpaste brand. But there's a lot more to this 217-year old company than you may think. We think this stock may be the best way to gain exposure to the growth in pet care.
However, we cannot talk about this company without addressing its decline in the past…
$100bn biotechs like Vertex Pharmaceuticals (NDQ:VRTX) typically get to their position through 'blockbuster drugs' with periods of market exclusivity, which eventually come to an end and cause revenues to fall as cheaper biosimilars come onto the market. The average biotech is facing a loss of revenue of 38%. Of course, some are higher (i.e. Amgen…
This week's international stock deep dive in on Walmart (NYSE:WMT). While most of our Australian readers may not have shopped there, many will have heard about it - even if it is just because they own a small cap that has a deal to sell their product into Walmart outlets.
Being the company that it is,…
Airbnb (NDQ:ABNB) has been a fascinating company to watch since listing in December 2020. On one hand it has not performed as investors may have expected.
It listed at a time that was arguably the worst time to do - when the industry was shut down. But shares held up well, and there surely was more…
The dream run Pfizer had during the pandemic was not going to last forever. But while certain companies that derived a windfall during the pandemic (one example being Sonic (ASX:SHL)) had decent businesses pre-COVID and began to 'normalise' post-pandemic, Pfizer has continued to decline (shares have dropped another 12% in 2025).
What are the Best ASX…
